In today’s column, I analyze an important symposium on AI for mental health that took place at Stanford University on June 1, 2026, an event that was part of Stanford’s notable initiative known as AI4MH (AI for mental health).
Avid readers know that I have been covering this crucial and groundbreaking Stanford AI4MH initiative on an ongoing basis; for example, see my coverage at the link here and the link here. This exciting initiative is under the auspices of the Stanford School of Medicine, Department of Psychiatry and Behavioral Sciences — details about AI4MH can be found at the link here. The stated purpose of AI4MH is to transform research, diagnosis, and treatment of psychiatric and behavioral disorders by creating and using responsible AI, including the creation of AI tools tailored towards psychiatric applications, facilitating their use within the department, fostering interdisciplinary collaborations, and providing cutting-edge knowledge.
In addition to AI4MH’s numerous webinars throughout the year, this bold AI4MH Symposium was the first of what I hope will be an annual conference series. The stellar event brought together a bevy of stakeholders, including researchers, scholars, practitioners, vendors, lawmakers, and the like, aiming to discuss where AI for mental health has been and where it is likely headed.
Let’s talk about it.
This analysis of AI breakthroughs is part of my ongoing Forbes column coverage on the latest in AI, including identifying and explaining various impactful AI complexities (see the link here).
AI And Mental Well-Being
As a quick background, I’ve been extensively covering and analyzing a myriad of facets regarding the advent of modern-era AI that generates mental health advice and performs AI-driven therapy. This rising use of AI has principally been spurred by the evolving advances and widespread adoption of generative AI and large language models (LLMs). For an extensive listing of my well over 150 analyses and postings on this evolving realm, see the link here and the link here.
There is little doubt that this is a rapidly developing field and that there are tremendous upsides to be had, but at the same time, regrettably, hidden risks and outright gotchas come into these endeavors, too. I frequently speak up about these pressing matters, including in an appearance on an episode of CBS’s 60 Minutes; see the link here.
AI Providing Mental Health Guidance
First, I’d like to share some overarching background about the AI for mental health domain. After doing so, I will dive into some selected highlights from the recent symposium.
Many millions of people are currently using generative AI as their ongoing advisor on mental health considerations (note that ChatGPT alone has over 900 million weekly active users, a notable proportion of which dip into mental health aspects; see my analysis at the link here). Surveys show that the top-ranked use of contemporary generative AI and LLMs is to consult with the AI on mental health facets; see my discussion at the link here.
This popular usage makes abundant sense. You can access most of the major generative AI systems for nearly free or at a super low cost, doing so anywhere and at any time. Thus, if you have any mental health qualms that you want to chat about, all you need to do is log in to AI and proceed forthwith on a 24/7 basis.
There are significant worries that AI can readily go off the rails or otherwise dispense unsuitable or even egregiously inappropriate mental health advice. Banner headlines keep arising as lawsuits concerning AI providing mental health advice or faltering in catching mental health crises come to public attention. AI makers are stridently devising and fielding AI safeguards in an effort to mitigate or prevent untoward AI actions.
Today’s generic LLMs, known as general-purpose AI (GPAI), such as ChatGPT, GPT-5, Claude, Gemini, Grok, CoPilot, and others, are not yet akin to the robust capabilities of human therapists. Meanwhile, specialized LLMs referred to as purpose-built AI (PBAI) are being built to provide robust mental health advice, though they are in the early stages of advancement and marketplace acceptance. See my detailed coverage at the link here.
Budding Laws On AI Mental Health
A beehive of activity is taking place regarding crafting new AI laws associated with regulating AI for mental health, principally arising on a state-by-state basis. See my extensive coverage of state-level AI mental health laws at the link here. Some policymakers and lawmakers ardently believe that AI and AI makers are being allowed to run amok, while others insist that innovation takes precedence and that new AI laws will adversely impede important progress.
It is too early to know whether these new AI laws will survive legal battles inevitably waged by AI makers and other contenders. Just because AI laws are enacted does not mean they are going to withstand legal scrutiny. All sorts of improper provisions and constitutionally contentious stipulations are undoubtedly buried within these shiny new AI laws.
Congress has repeatedly waded into establishing a comprehensive federal law that would encompass AI for mental health. So far, no dice. The efforts have ultimately faded from view. The big question will be to what degree a sweeping federal law would impact the numerous state-level AI laws. The odds are that many of the state-level laws would run afoul of a federal mandate, and a tsunami of legal cases would arise as a tussle between federal law and state law is undertaken. It surely will be a colossal legal mess.
Readers might recall that I proposed a 7-step AI-law-making process that I believe could substantively help regulators to devise new AI laws that are on target and balanced; see my depiction at the link here. This has an added benefit of reducing what I refer to as AI-law legal debt. This refers to AI laws that, though they look pristine, contain hidden debt that must ultimately be paid. Legal glitches and hitches will eventually be found when hurriedly devised AI laws are passed without suitable scrutiny and analysis.
The AI4MH Symposium
AI4MH undertook a major symposium on June 1, 2026, entitled “Foundations, Frontiers, and the Real World: Shaping AI’s Role in Mental Health.” For the agenda of this significant event, see the link here. This event was co-organized by Stanford AI4MH and Stanford HAI, and the corporate sponsor was Wonder Sciences.
There were six segments comprising the core of the AI4MH Symposium:
- (1) Opening Remarks
- (2) Keynote Panel
- (3) Academic Research: Foundation & Frontiers
- (4) Industry & Translation: What It Takes to Deploy
- (5) Policy & Ethics: Governing AI in Mental Health
- (6) Closing Remarks
I will highlight next various selected points and insights. Please know that this half-day event was chock-full of useful information, and, due to the limited space available here, I’ll aim primarily to whet your appetite with selected aspects that caught my eye. I urge those who are keenly interested in the realm of AI for mental health to consider watching the official video recording of the AI4MH event; see the link here.
(2) Keynote Panel
The keynote panel consisted of:
- Carolyn Rodriguez, MD, PhD (panel moderator), Professor of Psychiatry and Behavioral Sciences, Associate Dean for Academic Affairs, Stanford University School of Medicine; AI4MH Co-Director.
- Ehsan Adeli, PhD (panelist), Assistant Professor of Psychiatry and Behavioral Sciences and, by courtesy, of Computer Science and of Biomedical Data Science; AI4MH Co-Director.
- Brandon Staglin, MS (panelist), Co-Founder, Chief Advocacy & Engagement Officer of One Mind and Chair of the One Mind Lived Experience Council.
- Vaile Wright, PhD (panelist), Senior Director for Health Care Innovation at the American Psychological Association.
During the keynote panel, one consideration that came up and that is not widely understood by the public at large is that the rising need for mental health services can’t be met by human therapists alone. The demand side for therapy is far in excess of the available supply of therapists. This means that many who need or desire therapy will be left in a lurch. What can be done about this?
A strident possibility is to lean into AI that is suitably devised for mental health support. Human therapists can leverage AI and accomplish more by using AI as a therapeutic tool with their clients. In addition, AI can potentially be used as a standalone mechanism for those who otherwise cannot readily access a human therapist. I have framed this as a transformation of the classic dyad of therapist-client into a new triad of therapist-AI-client, whereby AI is an integral component for psychotherapy; see the link here.
Another notable point that was made involves the prevailing myopic focus on text-based AI for mental health, which is the predominant mode currently, but will soon be eclipsed by multi-modal interactions. Multi-modal AI opens the door toward a much more robust means of engaging in mental health discernment and therapeutic practice. This is not some futuristic sci-fi aspect. It is getting nearer, and we must do more to prepare for and guide how multi-modal AI for mental health is going to emerge and be put into practice; see my discussion at the link here.
The importance of lived experience regarding mental health was brought to the fore when Brandon Staglin provided deeply personal remarks about his schizophrenia recovery during his youth. This was quite heart-wrenching and yet a fully inspirational telling since he ultimately turned that lived experience into a lifelong effort to spur mental health innovation and advocacy. Via One Mind, he continues as a vocal champion for lived experience-based guidance in devising the future of mental health systems.
(3) Academic Research: Foundation & Frontiers
The academic research panel consisted of:
- Leanne Williams, PhD (moderator), Vincent V.C. Woo Professor and Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator).
- Alexis Hiniker, PhD (panelist), Associate Professor, University of Washington Information School Co-Director, Center for Digital Youth. Talk Title: “Friend or Frenemy? AI Chatbots and Teen Mental Health”.
- H. Andrew Schwartz, PhD (panelist), Associate Professor of Computer Science & Psychology, Vanderbilt University. Talk Title: “Explaining GPT’s Schema of Depression: A Machine Behavior Analysis”.
- Shannon Wiltsey Stirman, PhD (panelist), Professor of Psychiatry and Behavioral Sciences, Stanford University; AI4MH Associate Director; Stanford CREATE Center Director. Talk Title: “Using Large Language Models to Support Access and Implementation to Effective Mental Health Treatment”.
The panel on academic research noted the significance of carrying out bona fide scientific research when it comes to designing, fielding, and assessing the impacts of AI for mental health. Methodological soundness is a must. Studies that do not adhere to proper and accepted research approaches can give false impressions and be misleading.
The use of RCTs (randomized controlled trials) is the gold standard for clinical research and ought to be a keystone in any serious work on this topic. I recently provided useful advice on how waitlist controls in the specific sphere of AI for mental health research should be suitably arranged; see the link here.
When I give talks about AI and mental health, I frequently mention that perhaps one-quarter to possibly one-third of those using generative AI are dipping into the AI for mental health advisement. During the panel remarks by Dr. Stirman, research findings as part of the Stanford CREATE Center were showcased, including that about 24%-33% of U.S. adults indeed are using LLMs for mental health. An added point was that this usage is not in direct avoidance of therapists or traditional care per se (which is a common myth perpetrated in the media).
CREATE is the Center for Responsible and Effective AI Technology Enhancement of PTSD Treatments at Stanford. For more about the innovative research underway at CREATE, you can visit their website at the link here. For some of my prior coverage about CREATE, see the link here and the link here.
(4) Industry & Translation: What It Takes to Deploy
The industry panel consisted of:
- Russ B. Altman, MD, PhD (moderator), Kenneth Fong Professor and Professor of Bioengineering, of Genetics, of Medicine, of Biomedical Data Science, Senior Fellow at the Stanford Institute for Human-Centered AI and Professor, by courtesy, of Computer Science.
- Sara Johansen, MD (panelist), Product Policy Lead for Mental Health and Well-Being, OpenAI. Talk Title: “Mental Health & Well-Being, Support across the spectrum”.
- Jina Suh, PhD, MS, MA (panelist), Principal Researcher, University of Washington, SafeMind Institute. Talk Title: “Beyond the Conversation: Designing the architecture around AI in mental health”.
One of the mantras that was repeatedly referred to during this session entails the aspect that AI for mental health meets people where they are. A person might need mental health assistance at 3 a.m. and not readily have a means to confer with their therapist at that late hour. AI stands ready on a 24/7 basis.
That being said, AI safeguards are sorely needed to keep AI on the right track at all times, night or day. Dr. Johansen described the role of model policies and product policies associated with AI for mental health. OpenAI recently introduced their Trusted Contacts feature, which I reviewed at the link here. AI makers are instituting a layered approach to mental health safeguards. Per the memorable words of Marcus Tullius Cicero: “The safety of the people shall be the highest law.”
(5) Policy & Ethics: Governing AI in Mental Health
The policy and ethics panel consisted of:
- Michelle Mello, JD, PhD (moderator), Professor of Law at Stanford Law School and Professor of Health Policy at the Stanford University School of Medicine.
- Assemblymember Mia Bonta (panelist), Member of the California State Assembly, 18th District.
- Nicole Martinez-Martin, JD, PhD (panelist), Assistant Professor (Research) of Pediatrics (Biomedical Ethics) and, by courtesy, of Psychiatry and Behavioral Sciences (Child and Adolescent Psychiatry and Child Development). Talk Title: “Ethical Issues for Mental Health AI”
- Jane P. Kim, PhD (panelist), Clinical Associate Professor of Psychiatry and Behavioral Sciences, Stanford University; AI4MH Associate Director. Talk Title: “Evaluating LLMs for Mental Health: Keeping humans in the loop”.
In the policy and ethics panel, Dr. Mello laid out the legal landscape associated with AI for mental health. One of the oft-noted and beguiling aspects concerns the FDA. Though many might assume that the FDA is right on top of the morass of AI apps that claim to provide mental health or well-being advisement, this is decidedly not the case. For my in-depth analysis of the FDA status in this realm, see the link here. And for what the FTC is doing, see my discussion at the link here.
The World Ahead
My above recap of the AI4MH Symposium represents a taste or sampling. I will be doing a series of in-depth pieces to cover some of the specific talks in further depth. Stay tuned.
A final thought for now.
AI has a dual-use effect. There are the downsides and the upsides. Just as AI can be potentially detrimental to mental health, it can also be a huge bolstering force for mental health. A determinative tradeoff must be mindfully managed. Generally, the goal is to prevent or mitigate the downsides and meanwhile make the upsides as widely and readily available as possible.
The realm of AI for mental health requires a wide array of well-thought-out perspectives, encompassing mental health professionals, behavioralists, psychologists, psychiatrists, AI researchers, AI developers, AI makers, legal experts, policymakers, lawmakers, and the public at large. It might be said that it takes a village to ensure that AI for mental health steers in the right direction. The stakes are high; namely, this is for the sake of humankind and the psyche of us all.
Let’s get this right.
